Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
234 Leser
Artikel bewerten:
(1)

Melzi Surgical to Present at the Virtual Investor Innovations in MedTech Event

Live video webcast with moderated roundtable with members of the Melzi leadership team and surgical Key Opinion Leaders on Wednesday, June 8th at 11:00 AM ET

RENO, NV / ACCESSWIRE / May 31, 2022 / Melzi Surgical ("Melzi" or the "Company"), a surgical device company dedicated to creating innovative technologies that improve patient outcomes while reducing hospital expenses, today announced that it will participate in the Virtual Investor Innovations in MedTech Event on Wednesday, June 8, 2022 at 11:00 AM ET.

Melzi Surgical, Tuesday, May 31, 2022, Press release picture

For the roundtable discussion, Reid Rutherford, Co-Founder and CEO and Samuel Weprin, MD, Co-Founder and Head of Product Innovation of Melzi Surgical will be joined by Key Opinion Leaders, Jay Shah, MD, Urology Oncologist, Vice Chief of Staff at Stanford Health Care, and Daniel D. Eun, MD, Chief, Robotic Surgery at Temple University Hospital. As part of the event, the Company will discuss its lead product, the Melzi Sharps Finder, the growing problem of surgical lost sharps, and the need for innovative technologies that improve patient outcomes while reducing hospital expenses.

The Company's Melzi Sharps Finder was designed by surgeons who understand how frustrating and time-consuming it can be to search for surgical needles and sharps. The use of an adjunct technology, like Melzi Sharps Finder, can bring patient safety, time, financial, and risk benefits. In a lab study, testing results show 13mm, 17mm, and 26mm needles detected at 95% reliability rate. Additionally, in two recently conducted evaluations of the Melzi Sharps Finder where time to locate (TTL), accuracy, and the time to decide (TTD) were recorded. All of the results from the evaluations were statistically significant.

In addition to the moderated portion of the event, investors and interested parties will have the opportunity to submit questions live during the event. The Company will answer as many questions as possible during the event.

A live video webcast of the Innovations in MedTech Event will be available on the event website, here. A webcast replay will be available two hours following the live presentation and will be accessible for 90 days following the event.

About Melzi Surgical
Melzi is a surgical device company dedicated to creating innovative technologies that improve patient outcomes while reducing hospital expenses. The Company's lead product, the Melzi Sharps Finder, is a U.S. FDA registered device designed to locate instruments, needles, broken pieces and fragments, or sharp objects ("sharps") that have been lost inside a patient during surgery. The Melzi Sharps Finder is an easy-to-use hand tool capable of working in a 5mm trocar for laparoscopic and robotic surgeries and can also be used in open surgery. In a lab study, testing results with the Melzi Sharps Finder show detection of 13mm, 17mm, and 26mm needles with a 95% reliability rate.

The use of an adjunct technology, like the Melzi Sharps Finder, can bring patient safety, time, financial, and risk benefits. The Melzi Sharps Finder is currently indicated for use in gastroenterology and urology surgeries.

For more information about the Company, please visit melzisurgical.com

Investor Contact:
Jenene Thomas, JTC Team
T: (US): +1 (833) 475-8247
E: melzi@jtcir.com

Business Development Contact:
Allen McClinton, Melzi Surgical
T: 650-272-8987
E: allen@melzicorp.com

SOURCE: Melzi Surgical



View source version on accesswire.com:
https://www.accesswire.com/703247/Melzi-Surgical-to-Present-at-the-Virtual-Investor-Innovations-in-MedTech-Event

© 2022 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.